Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.

《Therapeutics And Clinical Risk Management》是一本由Dove Medical Press Ltd.出版商出版的专业医学期刊，该刊创刊于2005年，刊期1 issue/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：卫生保健与服务 4区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖卫生保健与服务等领域，旨在及时、准确、全面地报道国内外卫生保健与服务工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为2.755，平均审稿速度16 Weeks。